scholarly journals Efficacy of betahistine plus cognitive behavioral therapy on residual dizziness after successful canalith repositioning procedure for benign paroxysmal positional vertigo

2018 ◽  
Vol Volume 14 ◽  
pp. 2965-2971 ◽  
Author(s):  
Tian-ju Wan ◽  
Yi-Chuan Yu ◽  
Xiao-gang Zhao ◽  
Ping Tang ◽  
Yong-shu Gong
Keyword(s):  
Cognitive Behavioral Therapy ◽  
Benign Paroxysmal Positional Vertigo ◽  
Behavioral Therapy ◽  
Cognitive Behavioral ◽  
Positional Vertigo ◽  
Canalith Repositioning Procedure ◽  
Paroxysmal Positional Vertigo

scholarly journals Effect of the Canalith Repositioning Procedure on Benign Paroxysmal Positional Vertigo. Posterior Canal Type.

1998 ◽  
Vol 91 (4) ◽  
pp. 341-345
Author(s):  
Ken HAYASHI ◽  
Naoki HAYASHI ◽  
Mamoru SUZUKI ◽  
Tohru TANIGAWA ◽  
Muneo TAKAMOTO ◽  
...  
Keyword(s):  
Benign Paroxysmal Positional Vertigo ◽  
Posterior Canal ◽  
Positional Vertigo ◽  
Canalith Repositioning Procedure ◽  
Paroxysmal Positional Vertigo

scholarly journals Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update)

2017 ◽  
Vol 156 (3_suppl) ◽  
pp. S1-S47 ◽  
Author(s):  
Neil Bhattacharyya ◽  
Samuel P. Gubbels ◽  
Seth R. Schwartz ◽  
Jonathan A. Edlow ◽  
Hussam El-Kashlan ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Benign Paroxysmal Positional Vertigo ◽  
Radiographic Imaging ◽  
Inappropriate Use ◽  
Central Nervous System Disorders ◽  
Positional Vertigo ◽  
Canalith Repositioning Procedure ◽  
Paroxysmal Positional Vertigo

Objective This update of a 2008 guideline from the American Academy of Otolaryngology—Head and Neck Surgery Foundation provides evidence-based recommendations to benign paroxysmal positional vertigo (BPPV), defined as a disorder of the inner ear characterized by repeated episodes of positional vertigo. Changes from the prior guideline include a consumer advocate added to the update group; new evidence from 2 clinical practice guidelines, 20 systematic reviews, and 27 randomized controlled trials; enhanced emphasis on patient education and shared decision making; a new algorithm to clarify action statement relationships; and new and expanded recommendations for the diagnosis and management of BPPV. Purpose The primary purposes of this guideline are to improve the quality of care and outcomes for BPPV by improving the accurate and efficient diagnosis of BPPV, reducing the inappropriate use of vestibular suppressant medications, decreasing the inappropriate use of ancillary testing such as radiographic imaging, and increasing the use of appropriate therapeutic repositioning maneuvers. The guideline is intended for all clinicians who are likely to diagnose and manage patients with BPPV, and it applies to any setting in which BPPV would be identified, monitored, or managed. The target patient for the guideline is aged ≥18 years with a suspected or potential diagnosis of BPPV. The primary outcome considered in this guideline is the resolution of the symptoms associated with BPPV. Secondary outcomes considered include an increased rate of accurate diagnoses of BPPV, a more efficient return to regular activities and work, decreased use of inappropriate medications and unnecessary diagnostic tests, reduction in recurrence of BPPV, and reduction in adverse events associated with undiagnosed or untreated BPPV. Other outcomes considered include minimizing costs in the diagnosis and treatment of BPPV, minimizing potentially unnecessary return physician visits, and maximizing the health-related quality of life of individuals afflicted with BPPV. Action Statements The update group made strong recommendations that clinicians should (1) diagnose posterior semicircular canal BPPV when vertigo associated with torsional, upbeating nystagmus is provoked by the Dix-Hallpike maneuver, performed by bringing the patient from an upright to supine position with the head turned 45° to one side and neck extended 20° with the affected ear down, and (2) treat, or refer to a clinician who can treat, patients with posterior canal BPPV with a canalith repositioning procedure. The update group made a strong recommendation against postprocedural postural restrictions after canalith repositioning procedure for posterior canal BPPV. The update group made recommendations that the clinician should (1) perform, or refer to a clinician who can perform, a supine roll test to assess for lateral semicircular canal BPPV if the patient has a history compatible with BPPV and the Dix-Hallpike test exhibits horizontal or no nystagmus; (2) differentiate, or refer to a clinician who can differentiate, BPPV from other causes of imbalance, dizziness, and vertigo; (3) assess patients with BPPV for factors that modify management, including impaired mobility or balance, central nervous system disorders, a lack of home support, and/or increased risk for falling; (4) reassess patients within 1 month after an initial period of observation or treatment to document resolution or persistence of symptoms; (5) evaluate, or refer to a clinician who can evaluate, patients with persistent symptoms for unresolved BPPV and/or underlying peripheral vestibular or central nervous system disorders; and (6) educate patients regarding the impact of BPPV on their safety, the potential for disease recurrence, and the importance of follow-up. The update group made recommendations against (1) radiographic imaging for a patient who meets diagnostic criteria for BPPV in the absence of additional signs and/or symptoms inconsistent with BPPV that warrant imaging, (2) vestibular testing for a patient who meets diagnostic criteria for BPPV in the absence of additional vestibular signs and/or symptoms inconsistent with BPPV that warrant testing, and (3) routinely treating BPPV with vestibular suppressant medications such as antihistamines and/or benzodiazepines. The guideline update group provided the options that clinicians may offer (1) observation with follow-up as initial management for patients with BPPV and (2) vestibular rehabilitation, either self-administered or with a clinician, in the treatment of BPPV.

Takotsubo Cardiomyopathy and Canalith Repositioning Procedure for Benign Paroxysmal Positional Vertigo

2010 ◽  
Vol 21 (02) ◽  
pp. 073-077 ◽  
Author(s):  
Selmin Karatayli-Ozgursoy ◽  
Larry B. Lundy ◽  
David A. Zapala ◽  
Keith R. Oken
Keyword(s):  
Chest Pain ◽  
Takotsubo Cardiomyopathy ◽  
Benign Paroxysmal Positional Vertigo ◽  
English Literature ◽  
Left Ventricular ◽  
Apical Ballooning Syndrome ◽  
Positional Vertigo ◽  
Ampulla Cardiomyopathy ◽  
Canalith Repositioning Procedure ◽  
Paroxysmal Positional Vertigo

Background: Takotsubo cardiomyopathy, also known as left ventricular apical ballooning syndrome, ampulla cardiomyopathy, or transient left ventricular dysfunction is characterized by chest pain, electrocardiographic changes, transient left ventricular apical aneurysm, and normal coronary arteries. Tako-tsubo is a round-bottomed, narrow-necked Japanese octopus trap and lends its name to takotsubo cardiomyopathy because of its resemblance to echocardiographic and ventricular angiographic images of the left ventricle in this condition. This appearance takes its source from peculiar, transient regional systolic dysfunction involving the left ventricular apex and mid-ventricle with hyperkinesis of the basal left ventricular segments. Benign paroxysmal positional vertigo (BPPV) is the most common cause of vertigo caused by peripheral vestibular dysfunction. The symptoms of BPPV are attributed to intralabyrinthine particles, presumed displaced otoconia. Thus, the treatment recommended for BPPV is head repositioning maneuvers. Purpose: To present the first takotsubo cardiomyopathy case in the English literature related to BPPV undergoing canalith repositioning procedure. Conclusion: This report will provide additional information for physicians encountering acute-onset chest pain and vertigo. It will also expand the spectrum of clinical correlates of the increasingly well recognized but poorly understood syndrome, takotsubo cardiomyopathy.

Sign in / Sign up

Export Citation Format

Share Document